Bridgewater, NJ, United States
Bridgewater, NJ, United States

LifeCell is a biotechnology company that develops and sells tissue grafts and become a leader in the field of regenerative medicine. In recent years, LifeCell's sales have grown at an average of 41% per year and profits up to 72% annually, due in part to rising sales of their human tissue product AlloDerm. In more recent years, sales have stabilized at 12% annually. AlloDerm is used during surgeries ranging from complex hernia repairs to breast reconstruction. Wikipedia.


Time filter

Source Type

Patent
LifeCell | Date: 2016-12-14

Methods for shaping tissue matrices are provided. The methods can be used to produce shaped tissue products that retain desired biologic properties without using chemical crosslinking agents.


Methods for preparing a non-human tissue matrix for transplantation are provided.


Patent
LifeCell | Date: 2016-10-21

Systems, devices, and methods of the present disclosure assist with management of tubes and hoses during surgical procedures. The systems, devices, and methods provide for the proper opening and closing of tubes to facilitate performance of steps in a surgical procedure.


Patent
LifeCell | Date: 2016-10-21

Systems, devices, and methods of the present disclosure assist with management of tubes and hoses during surgical procedures. The systems, devices, and methods provide for the proper opening and closing of tubes to facilitate performance of steps in a surgical procedure. Systems, devices, and methods of the present disclosure control fluid delivery to and from a medical device, including devices for tissue processing and cleaning.


Patent
LifeCell | Date: 2016-12-01

The invention features a dry platelet composition and methods of making and using the freeze-dried platelet composition.


Patent
LifeCell | Date: 2017-03-08

The present disclosure provides devices for implanting tissue or other substances within the body. The devices can include a feedback mechanism (62), which can assist a surgeon in implanting the tissue or other substances by preventing excess shear force or pressure on the tissue or substance to be implanted.


Methods and systems for stiffening of tissue are presented to allow improved processing. Solutions comprising an acid or a base can be contacted with tissue to stiffen one or more components of the tissue. The resulting stiffened tissue can be used in the creation of wound treatment devices.


Patent
LifeCell | Date: 2016-12-21

The present disclosure provides systems and methods for transfer of tissue or other materials such as adipose tissue. The systems and methods can include a vessel and a syringe to facilitate transfer of tissue between one or more vessels and tissue implantation devices.


Patent
LifeCell | Date: 2017-06-07

Methods of producing tissue matrices are provided. The methods can comprise selection of collagen-based tissues from animals based on desired mechanical and/or biologic properties relating to the age of a source animal. Furthermore, tissue matrices produced from animals including pigs selected at various ages to control mechanical properties are provided.


Patent
LifeCell | Date: 2017-06-21

Methods and devices for treatment of tissues are provided. The methods can be used to interlock a composition with tissue for protection or engagement of the tissue. The devices can be used to treat a number of treatment sites, for example, to provide structural support to injured or surgically altered tissues and/or to secure tissues and/or implants in place.

Loading LifeCell collaborators
Loading LifeCell collaborators